The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man
- PMID: 30989239
- PMCID: PMC6517354
- DOI: 10.1007/s00011-019-01235-x
The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man
Erratum in
-
Correction to: The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man.Inflamm Res. 2019 Jun;68(6):427. doi: 10.1007/s00011-019-01242-y. Inflamm Res. 2019. PMID: 31065724 Free PMC article.
Abstract
Objective: The heterodimeric IL-12 family member cytokines including, IL-12, IL-23, IL-27, and IL-35 and have multiple roles in regulating innate and adaptive immunity with crucial functions in inflammatory disorders such as psoriasis. Chain pairing promiscuity is a feature of the IL-12 family. Recently, based on murine data, a new family member, IL-39, was proposed, consisting of IL23p19 (shared with IL-23) and EBI3 (shared with IL-27 and IL-35). IL-39 has subsequently been implicated in experimental murine lupus. Given the success of IL-23p19 therapeutic targeting in diseases including psoriasis, it is of great interest to confirm the presence of IL-39 in man. Human IL-39 is yet to be either detected or expressed, which has halted research in this area.
Methods: Using a disulphide-linked human chimera protein composing of IL-23p19 and EBI3 human chains, we stimulated human leukocytes, and analysed cytokine secretion and STAT3 phosphorylation.
Results and conclusion: We report that this cytokine shows no activity in human cells. IL-39 chimera protein failed to induce either IL-6, IL-8, TNF, or IL-17A from leukocytes or STAT3 phosphorylation and thus, remains a 'theoretical cytokine' in humans.
Keywords: Cytokine; IL-23; IL-39; Lupus; Psoriasis.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous